Labverity
Facility profile

Octapharma AB

Testing & analysis · Drug product manufacturing · Stockholm · Sweden

FDA recordFDA directory updated Jul 21, 2026Profile not yet claimed5 registered company locations
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

AnalysisLabelManufacturePack
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 21, 2026

Latest matched inspection
Voluntary action indicated (VAI)

Sep 19, 2023 · FDA documented observations for voluntary correction.

Matched compliance actions
Past action on file · 2011

More than five years old · review later records.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched voluntary action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Ask what was corrected and review any later inspection or follow-up record.

Method and source details
View full inspection and compliance history6 inspection records

FDA inspection history

6 records, Jan 2009 – Sep 2023 · 0 NAI · 5 VAI · 1 OAI

DateClassProject areaCitationsFY
Sep 19, 2023VAIBlood and Blood ProductsYes2023
Sep 28, 2018VAIBlood and Blood Products2018
Apr 28, 2014VAIBlood and Blood Products2014
Jan 19, 2012VAIBlood and Blood Products2012
Jan 20, 2011OAIBlood and Blood Products2011
Jan 29, 2009VAIBlood and Blood Products2009

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

Apr 15, 2011Warning Letter · CBER
Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services